Bio Green Med Solution (BGMSP) Common Equity (2010 - 2026)

Bio Green Med Solution (BGMSP) has reported Common Equity for 17 consecutive years, with $7.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Common Equity rose 97.19% year-over-year to $7.2 million in Q2 2026; TTM through Jun 2026 was $7.2 million, a 97.19% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 414.72% from the prior year.
• Common Equity was $7.2 million for Q2 2026 at Bio Green Med Solution, up from $6.8 million in the prior quarter.
• Over five years, Common Equity peaked at $33.8 million in Q1 2022 and troughed at -$2.2 million in Q1 2024.
• A 5-year average of $8.6 million and a median of $6.7 million in 2023 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 458.15% in 2024 and jumped 831.55% in 2025, its largest moves.
• Over 5 years, Common Equity stood at $15.9 million in 2022, then tumbled by 96.19% to $607000.0 in 2023, then slumped by 458.15% to -$2.2 million in 2024, then soared by 414.72% to $6.8 million in 2025, then advanced by 4.65% to $7.2 million in 2026.
• The last three Common Equity figures came in at $7.2 million (Q2 2026), $6.8 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.